TABLE 8.
HPLC (Method A without Hydrolysis) (μmol/g) |
HPLC (Method B with Hydrolysis) (μmol/g) |
LC/MS (μmol/g) |
GC/MS (μmol/g) |
|||||||||
Ct | Erly | Adv | Ct | Erly | Adv | Ct | Erly | Adv | Ct | Erly | Adv | |
Totala | 6.61 | 3.81 | 1.14 | 8.51 | 7.16 | 1.90 | 4.47 | 4.50 | 1.05 | 4.77 | 3.53 | 0.85 |
Primary bile acids | ||||||||||||
CA | 0.00 | 0.00 | 0.24 | 0.00 | 0.00 | 0.62 | 0.01 | 0.01 | 0.17 | 0.03 | 0.04 | 0.12 |
CDCA | 0.00 | 0.04 | 0.15b | 0.00 | 0.16 | 0.35b | 0.00 | 0.02 | 0.17b | 0.01 | 0.03 | 0.16b |
CA + CDCA | 0.00 | 0.11 | 0.54b | 0.00 | 0.18 | 0.95b | 0.02 | 0.03 | 0.54b | 0.04 | 0.05 | 0.49b |
Secondary bile acids | ||||||||||||
DCA | 3.84 | 0.89 | 0.08b | 4.18 | 1.75 | 0.21b | 1.88 | 1.05 | 0.02b | 3.25 | 1.27 | 0.01b |
LCA | 1.46 | 0.78 | 0.00b | 2.07 | 2.50 | 0.00b | 1.48 | 0.91 | 0.01b | 0.31 | 0.17 | 0.02b |
DCA + LCA | 5.64 | 2.22 | 0.16b | 7.21 | 4.06 | 0.32b | 3.51 | 2.88 | 0.04b | 4.25 | 2.29 | 0.03b |
Ratios of primary and secondary bile acids | ||||||||||||
DCA/CA | — | 0.55 | 0.00b | — | 0.79 | 0.03b | 116.49 | 13.17 | 0.05b | 111.48 | 27.52 | 3.47b |
LCA/CDCA | 10.29 | 5.41 | 0.00b | 12.93 | 7.63 | 0.00b | 16.74 | 4.12 | 0.01b | 15.81 | 7.84 | 0.26b |
DCA + LCA/CA + CDCA | 48.62 | 17.30 | 0.01b | 58.12 | 14.59 | 0.04b | 149.91 | 14.41 | 0.04b | 77.04 | 29.65 | 0.05b |
Total bile acids, total and individual secondary bile acids, and secondary/primary bile acid ratios were significantly lower while total primary bile acids especially CDCA were significantly higher in advanced cirrhosis compared with the rest of the groups using all three methods. CA levels were not different between groups using any of the techniques.
P < 0.05 using Kruskal Wallis test.